Fig. 3.

Detection of soluble CRT in sera. Serum samples (not diluted) from patients were individually assayed for the presence of sCRT using CLEIA, and the results are expressed as CRT concentrations (ng/ml). A The level of the sCRT in sera of patients with lung cancer (n = 58) and that of healthy human subjects (HS, n = 40). B The level of the sCRT in sera of three different pathological types of patient groups. SqCa: Squamous cell carcinoma (n = 18); SCLC: small cell lung cancer (n = 21); AC: adenocarcinoma (n = 19). C The level of the sCRT in sera of patients without (n = 12) and with chemotherapy (n = 46). All the mean values were shown by horizontal lines